Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Morel

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2023
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's MacroglobulinemiaChristian Buske, Meletios A Dimopoulos, Alexander Grunenberg, et al.
Annals of Hematology|January 26, 2021
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohortFlorian Bouclet, Anne Calleja, Marie-Sarah Dilhuydy, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2023
Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variantsCoralie Bloch, Jean Philippe Jais, Marine Gil, et al.
NAR Cancer|January 29, 2025
Specific modulation of 28S_Um2402 rRNA 2'-<i>O</i>-ribose methylation as a novel epitranscriptomic marker of ZEB1-induced epithelial-mesenchymal transition in different mammary cell contextsChloé Morin, Hermes Paraqindes, Flora Nguyen Van Long, et al.
British Journal of Haematology|November 13, 2023
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational studyLaurent Garderet, Hafida Ouldjeriouat, Mohamed-Amine Bekadja, et al.
Blood|September 3, 2021
Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experienceAlexis Caulier, Murielle Roussel, Pierre Morel, et al.
The Journal of Clinical Investigation|September 26, 2017
Mutations in the netrin-1 gene cause congenital mirror movementsAurélie Méneret, Elizabeth A Franz, Oriane Trouillard, et al.
Blood|July 17, 2014
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensusMeletios A Dimopoulos, Efstathios Kastritis, Roger G Owen, et al.
Haematologica|November 12, 2020
A prognostic index predicting survival in transformed Waldenström macroglobulinemiaEric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2024
Intricate ribosome composition and translational reprogramming in epithelial-mesenchymal transitionChloé Morin, Agnès Baudin-Baillieu, Flora Nguyen Van Long, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2023
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's MacroglobulinemiaChristian Buske, Meletios A Dimopoulos, Alexander Grunenberg, et al.
Annals of Hematology|January 26, 2021
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohortFlorian Bouclet, Anne Calleja, Marie-Sarah Dilhuydy, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2023
Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variantsCoralie Bloch, Jean Philippe Jais, Marine Gil, et al.
NAR Cancer|January 29, 2025
Specific modulation of 28S_Um2402 rRNA 2'-<i>O</i>-ribose methylation as a novel epitranscriptomic marker of ZEB1-induced epithelial-mesenchymal transition in different mammary cell contextsChloé Morin, Hermes Paraqindes, Flora Nguyen Van Long, et al.
British Journal of Haematology|November 13, 2023
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational studyLaurent Garderet, Hafida Ouldjeriouat, Mohamed-Amine Bekadja, et al.
Blood|September 3, 2021
Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experienceAlexis Caulier, Murielle Roussel, Pierre Morel, et al.
The Journal of Clinical Investigation|September 26, 2017
Mutations in the netrin-1 gene cause congenital mirror movementsAurélie Méneret, Elizabeth A Franz, Oriane Trouillard, et al.
Blood|July 17, 2014
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensusMeletios A Dimopoulos, Efstathios Kastritis, Roger G Owen, et al.
Haematologica|November 12, 2020
A prognostic index predicting survival in transformed Waldenström macroglobulinemiaEric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2024
Intricate ribosome composition and translational reprogramming in epithelial-mesenchymal transitionChloé Morin, Agnès Baudin-Baillieu, Flora Nguyen Van Long, et al.
Pageof 16